398 related articles for article (PubMed ID: 29773426)
81. Novel characteristics for immunophenotype, FISH pattern and molecular cytogenetics in synovial sarcoma.
Zhong LL; Huang GX; Xian LY; Wei ZC; Tang ZP; Chen QY; Chen H; Tang F
Sci Rep; 2023 May; 13(1):7954. PubMed ID: 37193761
[TBL] [Abstract][Full Text] [Related]
82. Inhibition of SOX2 induces cell apoptosis and G1/S arrest in Ewing's sarcoma through the PI3K/Akt pathway.
Ren C; Ren T; Yang K; Wang S; Bao X; Zhang F; Guo W
J Exp Clin Cancer Res; 2016 Mar; 35():44. PubMed ID: 26969300
[TBL] [Abstract][Full Text] [Related]
83. Histology and grading are important prognostic factors in synovial sarcoma.
Bianchi G; Sambri A; Righi A; Dei Tos AP; Picci P; Donati D
Eur J Surg Oncol; 2017 Sep; 43(9):1733-1739. PubMed ID: 28579008
[TBL] [Abstract][Full Text] [Related]
84. Role of fine needle aspiration cytology in the diagnosis of a rare case of a poorly differentiated synovial sarcoma with "Rhabdoid" features, including treatment implications.
Rekhi B; Shetty O; Ramadwar M; Rangarajan V; Bajpai J
Diagn Cytopathol; 2017 Jul; 45(7):662-667. PubMed ID: 28345284
[TBL] [Abstract][Full Text] [Related]
85. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients.
Ladanyi M; Antonescu CR; Leung DH; Woodruff JM; Kawai A; Healey JH; Brennan MF; Bridge JA; Neff JR; Barr FG; Goldsmith JD; Brooks JS; Goldblum JR; Ali SZ; Shipley J; Cooper CS; Fisher C; Skytting B; Larsson O
Cancer Res; 2002 Jan; 62(1):135-40. PubMed ID: 11782370
[TBL] [Abstract][Full Text] [Related]
86. Differential roles of SS18-SSX fusion gene and insulin-like growth factor-1 receptor in synovial sarcoma cell growth.
Törnkvist M; Natalishvili N; Xie Y; Girnita A; D'Arcy P; Brodin B; Axelson M; Girnita L
Biochem Biophys Res Commun; 2008 Apr; 368(3):793-800. PubMed ID: 18267106
[TBL] [Abstract][Full Text] [Related]
87. Predominantly epithelial-type synovial sarcoma with overwhelming neuroendocrine differentiation: a potential diagnostic pitfall.
Chen Y; Zhou N; Guo D; Wang X; He X; Xu Y
Diagn Pathol; 2022 Jul; 17(1):59. PubMed ID: 35820955
[TBL] [Abstract][Full Text] [Related]
88. Expression of TLE1, INI1, β-catenin, Claudin1, CK7, CK19, SS18 and calponin in synovial sarcoma.
Madakshira MG; Radotra BD; Kaman L; Saikia UN
Indian J Pathol Microbiol; 2021; 64(4):707-716. PubMed ID: 34673590
[TBL] [Abstract][Full Text] [Related]
89. Beta-catenin nuclear expression correlates with cyclin D1 expression in primary and metastatic synovial sarcoma: a tissue microarray study.
Horvai AE; Kramer MJ; O'Donnell R
Arch Pathol Lab Med; 2006 Jun; 130(6):792-8. PubMed ID: 16740029
[TBL] [Abstract][Full Text] [Related]
90. Detection of the SYT-SSX fusion transcripts in formaldehyde-fixed, paraffin-embedded tissue: a reverse transcription polymerase chain reaction amplification assay useful in the diagnosis of synovial sarcoma.
Lasota J; Jasinski M; Debiec-Rychter M; Szadowska A; Limon J; Miettinen M
Mod Pathol; 1998 Jul; 11(7):626-33. PubMed ID: 9688183
[TBL] [Abstract][Full Text] [Related]
91. Tissue microarray validation of epidermal growth factor receptor and SALL2 in synovial sarcoma with comparison to tumors of similar histology.
Nielsen TO; Hsu FD; O'Connell JX; Gilks CB; Sorensen PH; Linn S; West RB; Liu CL; Botstein D; Brown PO; van de Rijn M
Am J Pathol; 2003 Oct; 163(4):1449-56. PubMed ID: 14507652
[TBL] [Abstract][Full Text] [Related]
92. SS18-SSX2 and the mitochondrial apoptosis pathway in mouse and human synovial sarcomas.
Jones KB; Su L; Jin H; Lenz C; Randall RL; Underhill TM; Nielsen TO; Sharma S; Capecchi MR
Oncogene; 2013 May; 32(18):2365-71, 2375.e1-5. PubMed ID: 22797074
[TBL] [Abstract][Full Text] [Related]
93. Expression of CD133 in synovial sarcoma.
Terry J; Nielsen T
Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):159-65. PubMed ID: 19752721
[TBL] [Abstract][Full Text] [Related]
94. A clinicopathologic study on SS18 fusion positive head and neck synovial sarcomas.
Owosho AA; Estilo CL; Rosen EB; Yom SK; Huryn JM; Antonescu CR
Oral Oncol; 2017 Mar; 66():46-51. PubMed ID: 28249647
[TBL] [Abstract][Full Text] [Related]
95. Diagnostic accuracy of FISH and RT-PCR in 50 routinely processed synovial sarcomas.
Ten Heuvel SE; Hoekstra HJ; Suurmeijer AJ
Appl Immunohistochem Mol Morphol; 2008 May; 16(3):246-50. PubMed ID: 18301245
[TBL] [Abstract][Full Text] [Related]
96. [Analysis of SYT/SSX1 and SYT/SSX2 fusion genes from synovial sarcoma].
Kekeeva TV; Riazantseva AA; Zavalishina LÉ; Andreeva IuIu; Babenko OV; Zaletaev DV; Frank GA
Mol Biol (Mosk); 2011; 45(5):840-4. PubMed ID: 22393780
[TBL] [Abstract][Full Text] [Related]
97. The classic prognostic factors tumor stage, tumor size, and tumor grade are the strongest predictors of outcome in synovial sarcoma: no role for SSX fusion type or ezrin expression.
ten Heuvel SE; Hoekstra HJ; Bastiaannet E; Suurmeijer AJ
Appl Immunohistochem Mol Morphol; 2009 May; 17(3):189-95. PubMed ID: 18997619
[TBL] [Abstract][Full Text] [Related]
98. NY-ESO-1 expression in synovial sarcoma and other mesenchymal tumors: significance for NY-ESO-1-based targeted therapy and differential diagnosis.
Lai JP; Robbins PF; Raffeld M; Aung PP; Tsokos M; Rosenberg SA; Miettinen MM; Lee CC
Mod Pathol; 2012 Jun; 25(6):854-8. PubMed ID: 22388761
[TBL] [Abstract][Full Text] [Related]
99. Expression of MYCN in pediatric synovial sarcoma.
Somers GR; Zielenska M; Abdullah S; Sherman C; Chan S; Thorner PS
Mod Pathol; 2007 Jul; 20(7):734-41. PubMed ID: 17464317
[TBL] [Abstract][Full Text] [Related]
100. The (epi)genetics of human synovial sarcoma.
de Bruijn DR; Nap JP; van Kessel AG
Genes Chromosomes Cancer; 2007 Feb; 46(2):107-17. PubMed ID: 17117414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
